Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Songze Song"'
Publikováno v:
The Journal of Antibiotics. 75:567-575
Bacterial infection caused by Multidrug-resistant Pseudomonas aeruginosa has become a tricky problem in clinical practice. In recent years, lots of efforts have been made the treatment this type of bacterial infection. Polymyxins, which usually act a
Autor:
Songze Song, Deyu Zhang, Jingyi Chen, Lin Qi, Mengting Zhang, Xiao Yang, Tianxing Ye, Qinong Ye, Jing Lin
Publikováno v:
Cancer Science.
Autor:
Yanzhu, Shi, Deyu, Zhang, Jingyi, Chen, Qiwei, Jiang, Songze, Song, Yue, Mi, Tao, Wang, Qinong, Ye
Publikováno v:
International Journal of Biological Sciences. 18:4233-4244
High frequent metastasis is the major cause of breast cancer (BC) mortality among women. However, the molecular mechanisms underlying BC metastasis remain largely unknown. Here, we identified six hub BC metastasis driver genes (BEND5, HSD11B1, NEDD9,
Autor:
Yanzhu, Shi, Xiangwei, Ge, Qiwei, Jiang, Tian, Xie, Yue, Mi, Songze, Song, Deyu, Zhang, Qinong, Ye
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 38(11)
Objective To establish the eukaryotic expression vector of Y-box-binding protein 1 (YB-1) with FLAG-tagged and transfect it into hepatocellular carcinoma HepG2 cells to identify the effects of YB-1 on the proliferation and migration. Methods Human YB
Background: Resveratrol has been reported to have synergistic effect with different antibiotics against various kinds of bacteria species. In this study, we investigated if resveratrol can increase the antimicrobial efficacy of polymyxin B against mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdda8b5e8b259fef8eca950d1ec966bf
https://doi.org/10.21203/rs.3.rs-1359376/v1
https://doi.org/10.21203/rs.3.rs-1359376/v1
Autor:
Xiangwei Ge, Deyu Zhang, Songze Song, Yue Mi, Yanjie Shen, Qiwei Jiang, Yingchun Liang, Jinliang Wang, Qinong Ye
Publikováno v:
Biochemical and biophysical research communications. 599
Paclitaxol is a first-line treatment for triple-negative breast cancer (TNBC). The molecular mechanisms underlying paclitaxol resistance in TNBC remain largely unclear. In this study, differential expressed genes (DEGs) between TNBC cells and paclita